{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:28:36Z","timestamp":1789075716434,"version":"build-2803163510"},"reference-count":32,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003819","name":"natural science foundation of hubei province","doi-asserted-by":"publisher","award":["2022CFB622"],"award-info":[{"award-number":["2022CFB622"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical and Health Research Project of Yichang Science and Technology Bureau","award":["A23-1-014"],"award-info":[{"award-number":["A23-1-014"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To comprehensively clarify various treatment options for Trans-Atlantic Inter-Society Consensus (TASC) II C and D aorto-iliac occlusive disease (AIOD) through network meta-analysis (NMA), thus offering in-depth perspectives for clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic literature search of PubMed, Embase, Cochrane Library, and Web of Science was performed to identify controlled studies of operative treatment for AIOD. After quality assessment of the included studies, an NMA was performed using Stata software for primary outcomes: primary patency rate (1, 2, 3, and 5 years), and secondary outcomes: early postoperative mortality and perioperative complication rates. This study was prospectively registered in PROSPERO (ID: CRD42024535252).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifteen studies involving 7 surgical treatments were included aorto-femoral bypass (AoFB), axillofemoral bypass (AxFB), femoral-femoral bypass (FFB), aorto-iliac bypass (AIB), kissing covered stent (KS), covered endovascular reconstruction of aortic bifurcation (CERAB), and hybrid surgery. Results of the NMA indicated that compared with AoFB, CERAB had a comparable 1-, 2-, 3-, and 5-year postoperative primary patency rates. The AxFB yielded the lowest 1-year (odds ratio [OR]=0.31, 95% confidence interval [CI]=0.14-0.71) postoperative primary patency rates, and the same trend was maintained at 2-year (OR=0.29, 95% CI=0.15-0.56) and 3-year (OR=0.31, 95% CI=0.14-0.68) post-operation. Surface under the cumulative ranking curve (SUCRA) analysis ranked CERAB the highest for the 2-, 3- and 5-year postoperative primary patency rates (75.9% vs 91.9% vs 87.8%), with AxFB ranking the lowest (7% vs 19.5% vs 22.7%). The AxFB (77.8%) had the highest incidence of perioperative complications, followed by AIB (75.3%), with CERAB (3.7%) ranking the lowest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For patients with TASC II C and D AIOD, CERAB demonstrated a comparable durability in primary patency rates with AoFB and fewer perioperative complications than other interventions. The AxFB demonstrated the lowest postoperative primary patency rates and the highest incidence of perioperative complications. However, the mentioned limitations necessitate high-quality research to verify these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Impact<\/jats:title>\n                    <jats:p>For patients with TASC II C and D AIOD, CERAB demonstrated a comparable durability in primary patency rates with AoFB and fewer perioperative complications than other interventions. The AxFB demonstrated the lowest postoperative primary patency rates and the highest incidence of perioperative complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15266028251397886","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:43:14Z","timestamp":1764754994000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment Options for TASC II C and D Aorto-iliac Occlusive Disease: A Systematic Review and Network Meta-analysis"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-6419","authenticated-orcid":false,"given":"Kewei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4286-6457","authenticated-orcid":false,"given":"Yongpan","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3451-5002","authenticated-orcid":false,"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yichang Central People\u2019s Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"4","key":"e_1_3_2_2_2","first-page":"351","article-title":"Contemporary approaches for the management of aorto-iliac occlusive disease","volume":"64","author":"Wafi A","year":"2023","unstructured":"Wafi A, Hosny MS, Patel S, et al. Contemporary approaches for the management of aorto-iliac occlusive disease. J Cardiovasc Surg (Torino). 2023;64(4):351\u2013360.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"4","key":"e_1_3_2_3_2","first-page":"382","article-title":"Evolution of the covered endovascular reconstruction of the aortic bifurcation technique for complex aorto-iliac occlusive disease","volume":"64","author":"Ruffino MA","year":"2023","unstructured":"Ruffino MA, Konings TJ, Mees BM. Evolution of the covered endovascular reconstruction of the aortic bifurcation technique for complex aorto-iliac occlusive disease. J Cardiovasc Surg (Torino). 2023;64(4):382\u2013388.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2024.04.006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.01.053"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/17085381231166975"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-021-02785-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.12.035"},{"issue":"4","key":"e_1_3_2_9_2","first-page":"361","article-title":"Open management of complex infrarenal aortic occlusive disease","volume":"64","author":"Ilagan-Ying YC","year":"2023","unstructured":"Ilagan-Ying YC, Tonnessen BH. Open management of complex infrarenal aortic occlusive disease. J Cardiovasc Surg (Torino). 2023;64(4):361\u2013371.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"4","key":"e_1_3_2_10_2","first-page":"372","article-title":"Open surgical techniques for the management of complex juxtarenal aortic occlusions","volume":"64","author":"Tracci MC","year":"2023","unstructured":"Tracci MC, Paterson JE. Open surgical techniques for the management of complex juxtarenal aortic occlusions. J Cardiovasc Surg (Torino). 2023;64(4):372\u2013381.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.oa.19-00300"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2021.12.048"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac722"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2024.02.007"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.04.023"},{"issue":"5","key":"e_1_3_2_17_2","first-page":"560","article-title":"Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Primary Panel","year":"2022","unstructured":"Primary Panel; Abramson BL, Al-Omran M, et al. Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease. Can J Cardiol. 2022;38(5):560\u2013587.","journal-title":"Can J Cardiol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/15266028241237387"},{"issue":"6","key":"e_1_3_2_19_2","first-page":"905","article-title":"Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease","volume":"41","author":"Onohara T","year":"2000","unstructured":"Onohara T, Komori K, Kume M, et al. Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease. J Cardiovasc Surg (Torino). 2000;41(6):905\u2013910.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(96)70270-7"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0741-5214(92)90451-D"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/15385744221130870"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2022.10.022"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2024.03.014"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2024.06.008"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2021.10.040"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2023.12.021"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.08.139"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.06.107"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2019.02.002"},{"issue":"5","key":"e_1_3_2_31_2","first-page":"484","article-title":"Hybrid and open surgery of Trans-Atlantic Inter-Society II type C and D iliac occlusive disease and concomitant lesion of common femoral artery","volume":"35","author":"Starodubtsev V","year":"2016","unstructured":"Starodubtsev V, Karpenko A, Ignatenko P. Hybrid and open surgery of Trans-Atlantic Inter-Society II type C and D iliac occlusive disease and concomitant lesion of common femoral artery. Int Angiol. 2016;35(5):484\u2013491.","journal-title":"Int Angiol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2022.02.002"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/000313481307900131"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028251397886","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15266028251397886","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028251397886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:32:03Z","timestamp":1777498323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15266028251397886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":32,"alternative-id":["10.1177\/15266028251397886"],"URL":"https:\/\/doi.org\/10.1177\/15266028251397886","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"15266028251397886"}}